PT  - JOURNAL ARTICLE
AU  - Jiro Nakano
TI  - STUDIES ON THE CARDIOVASCULAR EFFECTS OF SYNTHETIC VASOPRESSIN
DP  - 1967 Jul 01
TA  - Journal of Pharmacology and Experimental Therapeutics
PG  - 19--31
VI  - 157
IP  - 1
4099  - http://jpet.aspetjournals.org/content/157/1/19.short
4100  - http://jpet.aspetjournals.org/content/157/1/19.full
SO  - J Pharmacol Exp Ther1967 Jul 01; 157
AB  - The effects of lysine-8-vasopressin (LVP) on the cardiovascular dynamics and myocardial oxygen metabolism were studied in anesthetized, open-chest dogs. It was found that the i.v. administration of 1 to 125 mU/kg of LVP decreased heart rate, pulmonary arterial pressure, cardiac output, systemic venous return and coronary blood flow. In addition, LVP increased mean systemic arterial pressure, left atrial pressure, left ventricular systolic and diastolic pressures, and total, pulmonary and coronary peripheral resistances essentially in proportion to the dose given. Furthermore, LVP decreased myocardial oxygen uptake, myocardial contractility and left ventricular performance. It is concluded that the reduction in cardiac output and left ventricular performance is most likely due to the decreased myocardial contractile force induced by the direct coronary constriction, to the marked increase in total peripheral resistance, and also to the decrease in the systemic venous return caused by the increased total peripheral capacitance. LVP decreased pulmonary arterial pressure owing to the marked decrease in right ventricular output which was induced by the decrease in systemic venous return and right ventricular contractile force in spite of the increase in left atrial pressure and pulmonary peripheral resistance. LVP tachyphylaxis and catecholamine hypersensitivity after LVP can be explained partially by the prolonged hemodynamic effects of LVP, especially in regard to its effect on the total peripheral capacitance. © 1967 by The Williams & Wilkins Company